| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 08-11-2021 |
| Asset Class: |
| Benchmark: NIFTY Healthcare TRI. |
| Expense Ratio: 2.35% As on (30-03-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 211.23 Cr As on (31-03-2026) |
| Turn over: 57 |
| 1-Year Ret (%) | 3-Yrs Ret (%) | 5-Yrs Ret (%) | 10-Yrs Ret (%) | Since Launch Ret (%) | |
|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | -2.75 | 18.58 | - | - | 10.29 |
| NIFTY Healthcare TRI | 5.6 | 23.05 | 13.18 | 9.72 | 14.48 |
| Equity: Sectoral-Pharma and Healthcare | 4.29 | 22.17 | 13.3 | 12.59 | 12.13 |
Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
| Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 14.52 | 0.68 | -2.77 | 0.9 | - | - |
| Equity: Sectoral-Pharma and Healthcare | - | - | - | - | - | - |